These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 12478337)
1. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study. Watanabe K; Kanaya H; Fujiyama Y; Kim P Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337 [TBL] [Abstract][Full Text] [Related]
2. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study]. Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961 [TBL] [Abstract][Full Text] [Related]
3. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas]. Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907 [TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent malignant supratentorial astrocytomas with carboplatin and etoposide combined with recombinant mutant human tumor necrosis factor-alpha. Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Ikeda K; Soma G; Fukushima T Anticancer Res; 2002; 22(4):2447-53. PubMed ID: 12174942 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D; Sipos L; Vitanovics D Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651 [TBL] [Abstract][Full Text] [Related]
7. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study. Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438 [TBL] [Abstract][Full Text] [Related]
8. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K; Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607 [TBL] [Abstract][Full Text] [Related]
9. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Hanna N; Gharpure VS; Abonour R; Cornetta K; Loehrer PJ Bone Marrow Transplant; 2001 Sep; 28(5):435-8. PubMed ID: 11593315 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050 [TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51. Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma]. Jeremić B; Grujicić D; Matović M Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813 [TBL] [Abstract][Full Text] [Related]
14. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889 [TBL] [Abstract][Full Text] [Related]
15. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596 [TBL] [Abstract][Full Text] [Related]
16. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials. Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine]. Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067 [TBL] [Abstract][Full Text] [Related]
18. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study. López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725 [TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Yung WK; Kyritsis AP; Gleason MJ; Levin VA Clin Cancer Res; 1996 Dec; 2(12):1931-5. PubMed ID: 9816151 [TBL] [Abstract][Full Text] [Related]
20. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Gnekow AK; Kortmann RD; Pietsch T; Emser A Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]